His primary areas of investigation include Immunology, Internal medicine, Tuberculosis, Acquired immunodeficiency syndrome and Sida. His research in Immunology intersects with topics in Clinical research, Epidemiology, Chemotherapy and Intensive care medicine. His studies in Internal medicine integrate themes in fields like Gastroenterology, Antibacterial agent and Surgery.
The study incorporates disciplines such as Placebo and Pediatrics in addition to Surgery. Gary Maartens has researched Tuberculosis in several fields, including Immune reconstitution inflammatory syndrome and Drug resistance. The Acquired immunodeficiency syndrome study combines topics in areas such as Incidence, Cohort study, Cohort and Confidence interval.
Gary Maartens focuses on Tuberculosis, Internal medicine, Immunology, Pharmacology and Acquired immunodeficiency syndrome. His Tuberculosis research includes elements of Prospective cohort study, Immune reconstitution inflammatory syndrome and Intensive care medicine. His Internal medicine study combines topics in areas such as Gastroenterology, Efavirenz, Surgery and Viral load.
His study connects Virology and Immunology. His work carried out in the field of Pharmacology brings together such families of science as Lopinavir, Rifampicin and Ritonavir. Gary Maartens interconnects Viral disease, Health care, Cohort study and Pediatrics in the investigation of issues within Acquired immunodeficiency syndrome.
The scientist’s investigation covers issues in Tuberculosis, Internal medicine, Pharmacokinetics, Dolutegravir and Regimen. His Tuberculosis research includes themes of Immune reconstitution inflammatory syndrome, Disease and Pediatrics. His work deals with themes such as Health care, Acquired immunodeficiency syndrome and Increased risk, which intersect with Disease.
His research integrates issues of Efavirenz and Emtricitabine in his study of Internal medicine. His Pharmacokinetics research is multidisciplinary, relying on both Rifampicin, Liter and Dosing. Attributable risk, Standardized mortality ratio, Demography, Interquartile range and Hazard ratio is closely connected to Viral load in his research, which is encompassed under the umbrella topic of Regimen.
His primary areas of study are Tuberculosis, Internal medicine, Confidence interval, Viral load and Disease. His study in Tuberculosis is interdisciplinary in nature, drawing from both Pediatrics and Lymphoma. His Internal medicine research includes elements of Efavirenz and Drug resistance.
Gary Maartens has included themes like Demography, Attributable risk and Confounding in his Confidence interval study. As part of his studies on Viral load, Gary Maartens frequently links adjacent subjects like Lopinavir. His Disease research incorporates themes from Transmission, Increased risk and Acquired immunodeficiency syndrome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings.
Graeme Meintjes;Stephen D Lawn;Stephen D Lawn;Fabio Scano;Gary Maartens.
Lancet Infectious Diseases (2008)
Outcomes after two years of providing antiretroviral treatment in Khayelitsha South Africa.
David Coetzee;Katherine Hildebrand;Andrew Boulle;Gary Maartens.
AIDS (2004)
HIV infection: epidemiology, pathogenesis, treatment, and prevention.
Gary Maartens;Connie L Celum;Sharon Ruth Lewin;Sharon Ruth Lewin;Sharon Ruth Lewin.
The Lancet (2014)
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
Jean B. Nachega;Michael Hislop;David W. Dowdy;Richard E. Chaisson.
Annals of Internal Medicine (2007)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley.
The Lancet Respiratory Medicine (2017)
Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
Jean B Nachega;Michael Hislop;Hoang Nguyen;David W Dowdy.
Journal of Acquired Immune Deficiency Syndromes (2009)
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.
Haileyesus Getahun;Wanitchaya Kittikraisak;Charles M. Heilig;Elizabeth L. Corbett.
PLOS Medicine (2011)
Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
Graeme Meintjes;Robert J Wilkinson;Chelsea Morroni;Dominique J Pepper.
AIDS (2010)
Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults.
Gary Maartens;Paul A. Willcox;Solomon R. Benatar.
The American Journal of Medicine (1990)
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.
Jean B. Nachega;Michael Hislop;David W. Dowdy;Melanie Lo.
Journal of Acquired Immune Deficiency Syndromes (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Cape Town
The Francis Crick Institute
University of Cape Town
The Francis Crick Institute
University of Pittsburgh
Johns Hopkins University
University of Aberdeen
University of Western Australia
University of Cape Town
University of Cape Town
University of Michigan–Ann Arbor
University of Maryland, Baltimore County
New York University
University of Electronic Science and Technology of China
Newcastle University
University of Sydney
Gwangju Institute of Science and Technology
University of Oxford
Duke University
University of Pennsylvania
Harvard University
Shimane University
Iowa State University
Friedrich-Loeffler-Institut
Johns Hopkins University
Harvard University